I am a consultant specializing in health economics, market access, and pricing, with over 20 years of experience spanning pharmaceuticals, medical devices, and consumer healthcare. My background includes strategy, business development, and finance, giving me a broad and connected understanding of the healthcare industry.

I have deep expertise in health technology assessment (HTA), pricing and reimbursement, regulatory processes, healthcare delivery, and financing. I understand payer priorities and evidence preferences across key global markets and have strong technical skills in health economics, including cost-effectiveness and cost-utility analysis, statistical methods, survival analysis, and discrete event simulation.

Currently, I serve as a member of the NICE Technology Appraisal Committee, contributing to critical decision-making in health policy. I am also recognized as a thought leader in value metrics for oncology survival.

As an accomplished project leader, I excel at delivering high-quality outcomes on time while adapting to evolving client needs. My ability to present complex concepts effectively and facilitate discussions ensures that stakeholders are engaged and aligned. With extensive commercial knowledge and a strategic mindset, I bring a comprehensive perspective to every project I undertake.